Asan Medical Center Ranked Leading in Korea
Middle East Medical Tourism Magazine
Seoul, South Korea
..
With a total of 2,680 hospital beds, Asan Medical Center (AMC) is
one of the leading hospitals in Korea. Each day, approximately 11,000
outpatients and 2,700 inpatients receive treatment at Asan Medical
Center, ranking first among Korean hospitals in terms of hospital size
and patient volume. This further strengthens Asan Medical Center's
position as a top choice for patients in Korea. Performing
approximately 57,000 advanced surgeries annually, Asan Medical
Center has established itself as a leader in surgical procedures in
Korea, treating approximately ten major cancers locally, in addition to
organ transplants, and treating approximately 30 common diseases in
Korea. Asan Medical Center has achieved unprecedented global
standards in organ transplantation and cancer treatment. Asan Medical
Center has performed the largest number of advanced surgical
procedures worldwide, exceeding 2,000 laparoscopic gastric cancer
surgeries, 3,000 kidney transplants, and 3,000 liver donations and
LDLT liver transplants. The center has also achieved impressive
results in metrics such as surgical success rates. Winning the hearts of
patients of various nationalities and those suffering from various
diseases by providing world-class healthcare services, Asan Medical
Center (AMC) dispatched its distinguished liver transplant team to
Mongolia, a country with one of the highest rates of fatal liver disease
in the world, and successfully performed Mongolia's first living donor
liver transplant (LDLT). In order to provide world-class, patient-
centered care, Asan Medical Center (AMC) has established IGS (Asan
Global Standard), an internal model for achieving global standards
through the participation and commitment of all members of the
organization to the benefits of IGS (Asan Global Standard), and 152
rules in 14 categories organized by type of work, criteria, and job
titles. By strictly adhering to these rules, Asan Medical Center (AMC)
consistently improves and enhances its processes and provides
patients with the best and safest medical services possible.
By starting operations at the Asan Institute of Medical Sciences, a
leading force in biotechnology research and development, Asan
Medical Center (AMC) has secured strong competition in the global
biotechnology market, including the development of new drugs and
treatments. Meanwhile, Asan Medical Center (IMC) has built a
modern infrastructure for biomedical research and has secured future
achievements through collaborative research and training projects,
with an increasing number of collaborative partnerships with global
medical institutions, research centers, and pharmaceutical companies.
Among Asan Medical Center's partner institutions are the Harvard-
affiliated Dana-Farber Cancer Institute and Imperial College London.
Asan Medical Center (IMC) aspires to transcend its position as
Korea's leading hospital and re-establish itself as one of the most
trusted hospitals globally. This is achieved by enhancing its
competitive advantage in the quality of its clinical services and
moving toward a win-win management approach through its
partnerships worldwide. Asan Medical Center's goal of pursuing
cutting-edge research is based on the organic relationship between
medicine and technology. Why is this relationship so important, and
how does Asan Medical Center (IMC) seek to achieve this? The Asan
Medical Center (AMC) R&D platform enables the immediate
implementation of cutting-edge laboratory discoveries, establishing
eight links between medicine and technology. The primary purpose of
this system is to advance research-based healthcare and promote
research products in the biomedical industry. Through the Center and
the Clinical Experimental Laboratory for Robotics, Asan Medical
Center (AMC) aims to immediately implement cutting-edge
laboratory discoveries in complex research. The Asan Medical Center
(AMC) Clinical Experimental Center is fully equipped with world-
class equipment and staff dedicated to advancing clinical research
through quality assurance, research support, and collaborative
activities with industry for biomedical innovations that benefit
patients. Through its "Global Center of Excellence," a locally
accredited center, the Asan Medical Center (AMC) Clinical
Experimental Center is taking a step toward becoming an
internationally recognized center of excellence in the field of
therapeutic testing. Asan Medical Center (AMC) is now developing
the latest medical robotics technologies for modern healthcare. Asan
Medical Center (AMC) launched its medical robotics technology in
February 2012, combining AMC's clinical expertise with Hyundai
Heavy Industries' (HHI) world-class robotics technology. Today, Asan
Medical Center (AMC) continues its search for the best future
treatment technologies.